QIAGEN acquisition of Formulatrix digital PCR assets
Acquisition07/01/2019
QIAGEN announced an agreement to acquire the digital PCR program assets of Formulatrix, Inc. to develop integrated digital PCR systems. Its 2019 annual report confirms the asset acquisition closed on January 31, 2019. This was an asset purchase, not acquisition of the whole Formulatrix company.
Type
Acquisition
Announced
07/01/2019
Amount
Financial data requires access
Reported parties
QIAGEN N.V.; Formulatrix digital PCR assets